Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic … – PR Newswire,

… Drug Candidate CB03 in First-in-Human Phase I Clinical Trial … “CB03 is the first drug candidate of Zhimeng to enter clinic trials in the …, … Drug Candidate CB03 in First-in-Human Phase I Clinical Trial … “CB03 is the first drug candidate of Zhimeng to enter clinic trials in the …, Read More

Scroll to Top